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INTRODUCTION 
Worldwide, the annual number of 
people diagnosed with diabetes continues to 
increase. Classically, Diabetes Mellitus (DM) 
has been associated with silent or atypical initial 
symptoms and increased time to presentation in 
patients presenting with ST elevation myocardial 
infarction (STEMI) compared to non-DM 
patients. It is less clear whether the type of 
treatment or the adequacy of glycemic control 
impacts the time to presentation and type of 
symptoms. Therefore, we sought to evaluate the 
impact of poor glycemic control on these 
outcomes as measured by hemoglobin A1c 
MATERIAL AND METHODS 
 In this retrospective study, we collected 
and analyzed data from 766 patients who 
presented to a tertiary-care university medical 
center with STEMI from 2008-2015. Over that 
timeframe, 238 of the 766 (31%) patients who 
presented with STEMI had DM. A T-test was 
performed comparing mean time to presentation 
in diabetics vs. non-diabetics, whereas both t-
tests and χ2 tests were used to compare 
presenting symptoms between the two groups. 
Regression analysis was performed comparing 
time to presentation to hemoglobin A1c. 
RESULTS 
Diabetic patients presenting with 
STEMI on average presented 50 minutes later 
than non- diabetic patients (194.8 minutes vs. 
144.7 minutes, p = 0.0054). Furthermore, time to 
presentation increased (p = 0.0035) for every 
unit increase in hemoglobin A1c level (p = 
0.0035). Chest pain was the most common 
presenting symptom in diabetic and non-diabetic 
patients with similar rates in both groups (87.4% 
v 89.1%, p = 0.561). No statistically significant 
difference was found in rates of shortness of 
breath, syncope, or GI symptoms between the 
two groups. 
CONCLUSION 
Diabetic patients have delayed time to 
presentation compared to non-diabetic patients 
with STEMI. Additionally, the worse the 
glycemic control the longer the time to 
presentation. However, in contrast to prior 
observations, both diabetic and non-diabetic 
patients presented with similar rates of chest 
pain. 
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